<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/mostaccessed/journal?journal=curropindrugdiscovdevel&amp;quantity=&amp;format=rss&amp;version=">
        <title>Current Opinion in Drug Discovery &amp; Development - Most accessed articles</title>
        <link>http://www.biomedcentral.com/curropindrugdiscovdevel/</link>
        <description>The most accessed research articles published by Current Opinion in Drug Discovery &amp; Development</description>
        <dc:date>2009-11-03T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                                <rdf:li rdf:resource="" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="">
        <title>The importance of target validation in drug discovery and development</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:581</dc:source>
        <dc:date>2009-09-04T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>581</prism:startingPage>
        <prism:publicationDate>2009-09-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Current parallel chemistry principles and practice: Application to the discovery of biologically active molecules</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:899</dc:source>
        <dc:date>2009-11-03T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>899</prism:startingPage>
        <prism:publicationDate>2009-11-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Future potential and status of selective sodium channel blockers
for the treatment of pain</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:682</dc:source>
        <dc:date>2009-09-04T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>682</prism:startingPage>
        <prism:publicationDate>2009-09-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Zero risk and zero benefit: Some thoughts on the control of genotoxic impurities</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:730</dc:source>
        <dc:date>2009-11-03T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>730</prism:startingPage>
        <prism:publicationDate>2009-11-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Direct small-molecule kinase activation: Novel approaches for a new era of drug discovery</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:585</dc:source>
        <dc:date>2009-09-04T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>585</prism:startingPage>
        <prism:publicationDate>2009-09-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Potassium trifluoroborate salts as convenient, stable reagents for difficult alkyl transfers</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:811</dc:source>
        <dc:date>2009-11-03T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>811</prism:startingPage>
        <prism:publicationDate>2009-11-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Patent alert</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:723</dc:source>
        <dc:date>2009-11-03T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>723</prism:startingPage>
        <prism:publicationDate>2009-11-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>A new generation of anti-histamines: Histamine H4 receptor antagonists on their way to the clinic</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:628</dc:source>
        <dc:date>2009-09-04T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>628</prism:startingPage>
        <prism:publicationDate>2009-09-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Resolvins: Current understanding and future potential in the control
of inflammation</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:644</dc:source>
        <dc:date>2009-09-04T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>644</prism:startingPage>
        <prism:publicationDate>2009-09-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="">
        <title>Paper alert</title>
        <description>No description available</description>
        <link></link>
                <dc:source>Current Opinion in Drug Discovery &amp; Development 2009, 12:707</dc:source>
        <dc:date>2009-11-03T00:00:00Z</dc:date>
        <dc:identifier>${item.identifier}</dc:identifier>
        <prism:publicationName>Current Opinion in Drug Discovery &amp; Development</prism:publicationName>
        <prism:issn>1367-6733</prism:issn>
        <prism:volume>12</prism:volume>
        <prism:startingPage>707</prism:startingPage>
        <prism:publicationDate>2009-11-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
